Oxidized Low-Density Lipoprotein (Ox-Ldl) Cholesterol Induces the Expression of Mirna-223 and L-Type Calcium Channel Protein in Atrial Fibrillation

Fengping He,Xin Xu,Shuguo Yuan,Liangqiu Tan,Lingjun Gao,Shaochun Ma,Shebin Zhang,Zhanzhong Ma,Wei Jiang,Fenglian Liu,Baofeng Chen,Beibei Zhang,Jungang Pang,Xiuyan Huang,Jiaqiang Weng
DOI: https://doi.org/10.1038/srep30368
IF: 4.6
2016-01-01
Scientific Reports
Abstract:Atrial fibrillation (AF) is the most common sustained arrhythmia causing high morbidity and mortality. While changing of the cellular calcium homeostasis plays a critical role in AF, the L-type calcium channel α1c protein has suggested as an important regulator of reentrant spiral dynamics and is a major component of AF-related electrical remodeling. Our computational modeling predicted that miRNA-223 may regulate the CACNA1C gene which encodes the cardiac L-type calcium channel α1c subunit. We found that oxidized low-density lipoprotein (ox-LDL) cholesterol significantly up-regulates both the expression of miRNA-223 and L-type calcium channel protein. In contrast, knockdown of miRNA-223 reduced L-type calcium channel protein expression, while genetic knockdown of endogenous miRNA-223 dampened AF vulnerability. Transfection of miRNA-223 by adenovirus-mediated expression enhanced L-type calcium currents and promoted AF in mice while co-injection of a CACNA1C-specific miR-mimic counteracted the effect. Taken together, ox-LDL, as a known factor in AF-associated remodeling, positively regulates miRNA-223 transcription and L-type calcium channel protein expression. Our results implicate a new molecular mechanism for AF in which miRNA-223 can be used as an biomarker of AF rheumatic heart disease.
What problem does this paper attempt to address?